Staphylococcus aureus bacteraemia as a quality indicator for hospital infection control

Medical Journal of Australia

Volumn 191, Issue 7, 2009, Pages 389-392

  Dendle, Claire ^a,b   Martin, Rhea D ^a   Cameron, Donna R ^a   Grabsch, Elizabeth A ^a   Mayall, Barrie C ^a   Grayson, M Lindsay ^a,b   Johnson, Paul D R ^a  

^a AUSTIN HEALTH   (Australia)

^b UNIVERSITY OF MELBOURNE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

CLONAL VARIATION; CONTROLLED STUDY; HEALTH CARE COST; HEALTH CARE FINANCING; HEALTH CARE SYSTEM; HEALTH PROGRAM; HOSPITAL INFECTION; HOSPITAL PATIENT; HUMAN; INFECTION CONTROL; LABORATORY TEST; MAJOR CLINICAL STUDY; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; NURSE CONSULTANT; REVIEW; STAPHYLOCOCCAL BACTEREMIA; VASCULAR ACCESS DEVICE;

EID: 77952298093     PISSN: 0025729X     EISSN: 13265377     Source Type: Journal    
DOI: 10.5694/j.1326-5377.2009.tb02847.x     Document Type: Review

References (23)

1. Cosgrove SE, Qi Y, Kaye KS, et al. The impact of methicillin resistance in Staphylococcus aureus bacteraemia on patient outcomes: mortality, length of stay, and hospital charges. Infect Control Hosp Epidemiol 2005; 26: 166-174. (Pubitemid 40445022)
2. Torvaldsen S, Roberts C, Riley TV. The continuing evolution of methicillin-resistant Staphylococcus aureus in Western Australia. Infect Control Hosp Epidemiol 1999; 20: 133-135.
3. Millar M, Coast J, Ashcroft R. Are methicillin-resistant Staphylococcus aureus bloodstream infection targets fair to those with other types of healthcare-associated infection or cost-effective? J Hosp Infect 2008; 69: 1-5.
4. Collignon P, Nimmo GR, Gottlieb T, Gosbell IB; Australian Group on Antimicrobial Resistance. Staphylococcus aureus bacteraemia, Australia. Emerg Infect Dis 2005; 11: 554-561.
5. Collignon PJ, Wilkinson IJ, Gilbert GL, et al. Health-care associated Staphylococcus aureus bloodstream infections: a clinical quality indicator for all hospitals. Med J Aust 2006; 184: 404-406.
6. Cruickshank M, Ferguson J, editors. Reducing harm to patients from health care associated infection: the role of surveillance. Sydney: Australian Commission on Safety and Quality in Health Care, 2008. http://www.health.gov.au/ internet/safety/publishing.nsf/Content/prog-HAI-Surveillance#report (accessed Aug 2009).
7. Department of Human Services, Tasmania. Guidelines for notification of notifiable diseases, human pathogenic organisms and contaminants. Public Health Act 1997. Issued 17 December 2008. http://www.dhhs.tas.gov.au/-data/assets/pdf- file/0019/31681/Notifiable-Diseases-Guidelines-Final1.pdf (accessed Aug 2009).
8. Johnson PD, Martin R, Burrell LJ, et al. Efficacy of an alcohol/chlorhexidine hand hygiene program in a hospital with high rates of nosocomial methicillin-resistant Staphylococcus aureus (MRSA) infection. Med J Aust 2005; 183: 509-514. (Pubitemid 41723325)
9. Australian Infection Control Association. Blood stream infection (BSI). http://www.health.qld.gov.au/chrisp/icare/aica-bsi-def-v1.pdf (accessed Aug 2009).
10. O'Grady NP, Alexander M, Dellinger EP, et al. Guidelines for the prevention of intravascular catheter-related infections. Centers for Disease Control and Prevention. MMWR Recomm Rep 2002; 51 (RR-10): 1-29.
11. Clinical and Laboratory Standards Institute. Performance standards for antimicrobial susceptibility testing. Fifteenth informational supplement (M100-S15 Vol. 25 No. 1). Wayne, Pa: CLSI, 2005.
12. Ballard SA, Pertile KK, Lim M, et al. Molecular characterization of vanB elements in naturally occurring gut anaerobes. Antimicrob Agents Chemother 2005; 49: 1688-1694. (Pubitemid 40631575)
13. Horan TC, Gaynes RP. Surveillance of nosocomial infections. In: Mayhall CG, editor. Hospital epidemiology and infection control. 3rd ed. Philadelphia: Lippincott Williams & Wilkins, 2004: 1659-1702.
14. Dreimanis D, Beckingham W, Collignon P, Roberts J. Staphylococcus aureus bacteraemia surveillance: a relatively easy to collect but accurate clinical indicator on serious health-care associated infections and antibiotic resistance. Aust Infect Control 2005; 10: 127-130.
15. Noskin GA, Rubin RJ, Schentag JJ, et al. The burden of Staphylococcus aureus infections on hospitals in the United States. Arch Intern Med 2005; 165: 1756-1761.
16. Rubin RJ, Harrington CA, Poon A, et al. The economic impact of Staphylococcus aureus infection in New York City hospitals. Emerg Infect Dis 1999; 5: 9-17. (Pubitemid 29124770)
17. Haley RW, Culver DH, White JW. The efficacy of infection surveillance and control programs in preventing nosocomial infections in US hospitals. Am J Epidemiol 1985; 121: 182-205.
18. Harbarth S, Sax H, Gastmeier P. The preventable proportion of nosocomial infections: an overview of published reports. J Hosp Infect 2003; 54: 258-266. (Pubitemid 37554920)
19. Eggimann P, Harbarth S, Constantin MN, et al. Impact of a prevention strategy targeted at vascular-access care on the incidence of infections acquired in intensive care. Lancet 2000; 355: 1864-1868. (Pubitemid 30311878)
20. Makasi H, Watanabe H, Degawa S, et al. Significant reduction of methicillin-resistant Staphylococcus aureus bacteremia in geriatric wards after introduction of infection control measures against nosocomial infections. Intern Med 2001; 40: 214-220. (Pubitemid 33611265)
21. Huang SS, Yokoe DS, Hinrichsen VL, et al. Impact of routine intensive care unit surveillance cultures and resultant barrier precautions in hospital-wide methicillin-resistant Staphylococcus aureus bacteraemia. Clin Infect Dis 2006; 43: 971-978.
22. Tomford JW, Hershey CO, McLaren CE, et al. Intravenous therapy team and peripheral venous catheter-associated complications. A prospective controlled study. Arch Intern Med 1984; 144: 1191-1194.
23. Berenholtz SM, Pronovost PJ, Lipsett PA, et al. Eliminating catheter-related bloodstream infections in the intensive care unit. Crit Care Med 2004; 32: 2014-2020. (Pubitemid 39372534)